dry eye disease

Shire commits up to $535M for Parion's dry eye drug
BioPharma Dive
Tue, 05/2/17 - 11:16 am
Shire
Parion
dry eye disease
P-321
Shire's DTC move to scrap smiling patients for double 'i's pays off—and it thinks other pharmas should take note
Fierce Pharma
Thu, 04/13/17 - 09:39 am
Shire
DTC ads
patients
Xiidra
dry eye disease
Restasis' first foray into Facebook drives big results for Allergan
Fierce Pharma
Mon, 04/10/17 - 10:03 am
Allergan
Restasis
dry eye disease
Facebook
social media
​Tiny Mass. biotech strikes licensing deal with Novartis worth up to $1B
Bizjournals.com
Thu, 04/6/17 - 11:58 pm
Novartis
Lubris
ECF843
dry eye disease
Allergan urges dry-eye sufferers to pump up their eye power
Fierce Pharma
Mon, 03/13/17 - 10:10 am
Allergan
dry eye disease
DTC ads
drug ads
Allergan Is Losing Its No. 2 Product More Rapidly Than Expected
Seeking Alpha
Wed, 12/21/16 - 10:53 am
Allergan
dry eye disease
Restasis
Shire
Xiidra
Allergan's Restasis Faces Dry Eye Threat: Examining XIIDRA's Initial Sales Trends
Seeking Alpha
Tue, 11/8/16 - 10:09 am
Allergan
dry eye disease
Restasis
Xiidra
Shire
Shire wants consumers and their eyes to be 'Friends'
BioPharma Dive
Thu, 10/13/16 - 10:40 am
Shire
celebrity endorsements
dry eye disease
Xiidra
Shire taps Jennifer Aniston for awareness campaign as it enters the eye care market
Medical Marketing and Media
Fri, 08/26/16 - 10:02 am
Shire
dry eye disease
Xiidra
celebrity endorsements
The Shire Vs. Allergan War Has Begun
Seeking Alpha
Mon, 08/1/16 - 09:39 am
Shire
Allergan
dry eye disease
Xiidra
Restasis
Shire targets Allergan's dry-eye market share by pricing Xiidra at $5K per year--right on par with Restasis
Fierce Pharma
Tue, 07/26/16 - 11:25 am
dry eye disease
Shire
Allergan
Xiidra
Restasis
Should Allergan Worry About Shire’s Win With Dry Eye Drug?
Bidness, ETC
Wed, 07/13/16 - 11:02 am
Allergan
Shire
dry eye disease
Restasis
Xiidra
Shire Secures Access to 16 Million-Strong US Dry Eye Disease Market With New Drug Approval
Forbes
Tue, 07/12/16 - 11:04 am
Shire
dry eye disease
FDA
Lifitegrast
Xiidra
Allergan’s Occuleve on track for FDA submission this year
Mass Device
Mon, 05/16/16 - 11:48 am
Allergan
Occuleve
devices
FDA
dry eye disease
nasal neurostimulation
Regeneron Eye Drug's Advantage Over Roche's Narrowed in Trial
Bloomberg
Sun, 02/28/16 - 10:52 am
Regeneron
dry eye disease
Roche
Lucentis
Eylea
Allergan execs see Restasis withstanding rivalry with prospective Shire med
Fierce Pharma Marketing
Wed, 02/24/16 - 10:50 am
Allergan
Shire
Restasis
Lifitegrast
dry eye disease
Shire's self-described blockbuster eye drug lines up for FDA do-over
Fierce Biotech
Sat, 02/6/16 - 12:18 pm
Shire
dry eye disease
FDA
Lifitegrast
Shire's back on track with its dry-eye threat to Allergan's Restasis
Fierce Pharma Marketing
Wed, 01/27/16 - 10:25 am
Shire
dry eye disease
Allergan
Restasis
Lifitegrast
Shire gets back on track with once-rejected eye drug
Fierce Biotech
Mon, 01/25/16 - 10:51 am
Shire
Lifitegrast
dry eye disease
Auven Therapeutics pits rival PhIII dry eye drug against Allergan, Shire
Fierce Biotech
Fri, 11/13/15 - 11:01 am
Auven Therapeutics
dry eye disease
Seciera
Restasis
Allergan
Shire
Lifitegrast

Pages